IL1B and breast cancer: Consistently, pre-clinical models of breast cancer showed that blockade of IL-1β secreted by macrophages in the TME resulted in the accumulation of tumor-infiltrating dendritic cells and the tumor-infiltrating CD8+ T cells [39], promoting tumor regression over time.